ATE175357T1 - Empfängnisverhütender impfstoff - Google Patents

Empfängnisverhütender impfstoff

Info

Publication number
ATE175357T1
ATE175357T1 AT93915326T AT93915326T ATE175357T1 AT E175357 T1 ATE175357 T1 AT E175357T1 AT 93915326 T AT93915326 T AT 93915326T AT 93915326 T AT93915326 T AT 93915326T AT E175357 T1 ATE175357 T1 AT E175357T1
Authority
AT
Austria
Prior art keywords
methods
sperm
contractive
vaccine
sperm surface
Prior art date
Application number
AT93915326T
Other languages
English (en)
Inventor
Paul Primakoff
Diana G Myles
Original Assignee
Univ Connecticut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Connecticut filed Critical Univ Connecticut
Application granted granted Critical
Publication of ATE175357T1 publication Critical patent/ATE175357T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT93915326T 1992-06-12 1993-06-10 Empfängnisverhütender impfstoff ATE175357T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US89788392A 1992-06-12 1992-06-12

Publications (1)

Publication Number Publication Date
ATE175357T1 true ATE175357T1 (de) 1999-01-15

Family

ID=25408584

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93915326T ATE175357T1 (de) 1992-06-12 1993-06-10 Empfängnisverhütender impfstoff

Country Status (8)

Country Link
EP (1) EP0646015B1 (de)
JP (1) JPH08503601A (de)
KR (1) KR950701821A (de)
AT (1) ATE175357T1 (de)
AU (1) AU4534893A (de)
CA (1) CA2137077A1 (de)
DE (1) DE69322960T2 (de)
WO (1) WO1993025233A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5693496A (en) * 1994-06-20 1997-12-02 Merck & Co., Inc. DNA encoding the mouse and human PH30 beta chain protein
AU3362895A (en) * 1994-08-11 1996-03-07 Duke University Use of zrk peptide sequences in contraception
ES2394035T3 (es) * 2008-04-07 2013-01-15 Auburn University Métodos para inmunocontracepción específica para ciertas especies de animales

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5721348A (en) * 1990-12-14 1998-02-24 University Of Connecticut DNA encoding PH-20 proteins
JPH07502886A (ja) * 1991-10-04 1995-03-30 ザ トラスティーズ オブ プリンストン ユニバーシティー 精子表面タンパク質

Also Published As

Publication number Publication date
EP0646015B1 (de) 1999-01-07
CA2137077A1 (en) 1993-12-23
KR950701821A (ko) 1995-05-17
JPH08503601A (ja) 1996-04-23
WO1993025233A1 (en) 1993-12-23
DE69322960D1 (de) 1999-02-18
AU4534893A (en) 1994-01-04
EP0646015A1 (de) 1995-04-05
DE69322960T2 (de) 1999-08-12

Similar Documents

Publication Publication Date Title
Mogensen et al. Raising antibodies to human leukocyte interferon
CO4850562A1 (es) Proceso para producir una preparacion concentrada de anticuerpos
FI932561A (fi) Proteiner med foeraendrade epitoper och foerfaranden foer deras framstaellning
DK0618813T3 (da) Antigen for M-hybridprotein og bærer for gruppe A streptococcal vaccine
CA2103887A1 (en) Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
YU48250B (sh) Postupak za pripremanje aktivne vakcine protiv lajmske bolesti
DE69418699D1 (de) Induktion der antworten zytotoxischer t-lymphozyten
DE69533594D1 (de) Präparate und verfahren zum auslösen von ctl-immunität
PT97159A (pt) Processo para a preparacao de uma proteina do antigenio de superficie da hepatite b ou de um seu fragmento e processo para a preparacao de uma vacina
GB2255093A (en) Hiv-1 core protein fragments
ES2194836T3 (es) Peptidos para su uso en vacunacion e induccion de anticuerpos neutralizantes contra el virus de la inmunodeficiencia humana.
ATE145246T1 (de) Monoklonale antikörper zur induzierung von toleranz
HUP9801223A2 (hu) Eljárás specifikus antigénekre adott antitest válasz fokozására interleukin-10-zel
EP2057999A3 (de) Verwendung von immunokonjugaten zur erhöhung der effektivität von mehrstufigen kaskaden-impfstoffen
EP0252064A3 (en) Preparations active against pseudomonas aeruginosa infections, and process for their preparation
DE3585370D1 (de) Kreuzreaktive und schuetzende epitope von circumsporozoit-proteinen.
ATE175357T1 (de) Empfängnisverhütender impfstoff
Larsson et al. Immunization with Nanogram Quantities of Nitrocellulose‐Bound Antigen, Electroblotted from Sodium Dodecyl Sulphate–Polyacrylamide Gels
ES2060695T3 (es) Concentrados terapeuticos de igm.
NO883501D0 (no) Slekt-spesifikt listeria-antigen identifisert med monoklonale antistoffer.
FI932759A0 (fi) Anvaendningen av IL-4 foer oekning av pao vacciners immunogener verkande immunreaktioner
EP0320866A3 (de) Schützendes immundominantes Epitop in der S1-Untereinheit von Pertussistoxin
NZ532271A (en) Peptide mimics of conserved gonococcal epitopes and methods and compositions using them
DK0542895T3 (da) Krydsreaktiv influenza A immunisering
IT1226728B (it) Coniugato peptidico immunologicamente attivo utile come vaccino antimalaria e metodo di immunizzazione impiegante lo stesso

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties